| Acute Myeloid Leukemia Post Cytotoxic Therapy studied in …STUDIED_INderived55 of 55show fewer |
|---|
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012044Phase 1 · recruiting A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554406Phase 2 · recruiting Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861314Phase 1 · active not recruiting Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03953898Phase 2 · active not recruiting Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04269213Phase 2 · completed CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284787Phase 2 · active not recruiting BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04062266Phase 2 · active not recruiting AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802161Phase 2 · active not recruiting Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214249Phase 2 · active not recruiting BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05146739Phase 1 · active not recruiting Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03330821Phase 1/Phase 2 · active not recruiting Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009240Phase 1 · completed Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554419Phase 2 · not yet recruiting Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292664Phase 1 · recruiting Venetoclax Basket Trial for High Risk Hematologic Malignancies · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226418Phase 2 · completed Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06950034Phase 1 · recruiting A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02381548Phase 1 · terminated Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06143839completed VYxeoS Liposomal Italian Observational Study iN the Real Practice · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760655Phase 2 · completed Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397720Phase 2 · completed Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658487Phase 2 · completed Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904136Phase 1/Phase 2 · completed Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823198Phase 1/Phase 2 · completed Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02642965Phase 1/Phase 2 · completed Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03272633early Phase 1 · terminated Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01238211Phase 2 · completed Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01420926Phase 2 · completed Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04518345early Phase 1 · completed TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02126553Phase 2 · completed Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253070Phase 2 · completed Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01834248Phase 1 · completed DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01640301Phase 1/Phase 2 · terminated Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602898Phase 2 · withdrawn Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307579Phase 3 · completed Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526926completed A Post-Marketing Observational Study of VYXEOS™ · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01619761Phase 1 · unknown NK Cells in Cord Blood Transplantation · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02323607Phase 1 · completed Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03365661Phase 2 · withdrawn QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01130506Phase 1 · completed Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 55 trials mapped (18 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 55 trials mapped (18 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |